IL-36 cytokines in autoimmunity and inflammatory disease

Liping Ding; Xiaohui Wang; Xiaoping Hong; Liwei Lu; Dongzhou Liu

doi:10.18632/oncotarget.22814

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

IL-36 cytokines in autoimmunity and inflammatory disease

Liping Ding, Xiaohui Wang, Xiaoping Hong, Liwei Lu and Dongzhou Liu _

PDF | HTML | How to cite

Oncotarget. 2018; 9:2895-2901. https://doi.org/10.18632/oncotarget.22814

Metrics: PDF 2451 views | HTML 4747 views | ?

Abstract

Liping Ding1, Xiaohui Wang2, Xiaoping Hong1, Liwei Lu2 and Dongzhou Liu1

1Department of Rheumatology and Immunology, Shenzhen People’s Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, China

2Department of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong, Hong Kong, China

Correspondence to:

Dongzhou Liu, email: [email protected]

Liwei Lu, email: [email protected]

Keywords: interleukin-36; inflammatory disease; psoriasis; arthritis

Received: September 29, 2017 Accepted: October 29, 2017 Published: December 01, 2017

ABSTRACT

The inteleukin-36 (IL-36) cytokines include IL-36α, IL-36β, IL-36γ and IL-36Ra, which belong to the IL-1 family and exert pro-inflammatory effects on various target cells such as keratinocytes, synoviocytes, dendritic cells and T cells. Emerging evidence has suggested a role of IL-36 in the pathogenesis of many inflammatory diseases. Here, we provide a brief review on the activation of IL-36 family cytokines and their involvement in autoimmunity and inflammatory diseases, which will provide further insights in understanding the functions of IL-36 family cytokines in the pathophysiology of autoimmunity and inflammatory diseases.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22814

Publication Alerts

Reviews:

IL-36 cytokines in autoimmunity and inflammatory disease

Abstract